Evidence map›Paper›PMID 26622417›Full record

ArticleExperimental and therapeutic medicine2015

Detection of AmpC β-lactamases in

Yongrui Liu, Xiangqun Liu

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. HypervirulentAntibiotics (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Frontiers in microbiology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Pan-Resistome Insights into the Multidrug Resistance ofAntibiotics (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Phenotypic Characterization and Antibiotic Resistance Patterns of Extended-SpectrumThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019
    Article
  13. Infection and drug resistance · 2018
    Review
  14. Article
  15. Biology ofFrontiers in cellular and infection microbiology · 2017
    Review
  16. Co-existence ofAntimicrobial resistance and infection control · 2017
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yongrui LiuDepartment of Respiration, The First People's Hospital of Jining, Shandong 272002, P.R. China.
Xiangqun LiuDepartment of Respiration, Xuzhou City Hospital Affiliated to Xuzhou Medical College, Xuzhou, Jiangsu 221002, P.R. China.
Jining First People's Hospital · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to determine the prevalence and related drug resistance of AmpC β-lactamases in

Indexed as

Acinetobacter baumanniiacinetobacter-derived cephalosporinaseAmpC β-lactamasespolymerase chain reaction

Identifiers

PMID26622417
PMCPMC4533231
OpenAlexW2171842758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.